Leveraging Real-World Data for the Selection of Relevant Eligibility Criteria for the Implementation of Electronic Recruitment Support in Clinical Trials

被引:14
|
作者
Melzer, Georg [1 ]
Maiwald, Tim [2 ]
Prokosch, Hans-Ulrich [1 ]
Ganslandt, Thomas [1 ,3 ]
机构
[1] Friedrich Alexander Univ Erlangen Nurnberg, Chair Med Informat, Wetterkreuz 15, D-91058 Erlangen, Germany
[2] Friedrich Alexander Univ Erlangen Nurnberg, Dept Elect Engn, Inst Elect Engn, Erlangen, Germany
[3] Heidelberg Univ, Mannheim Univ Med, Dept Biomed Informat, Heinrich Lanz Ctr Digital Hlth, Mannheim, Germany
来源
APPLIED CLINICAL INFORMATICS | 2021年 / 12卷 / 01期
关键词
electronic health records and systems; data warehousing and data marts; secondary use; clinical trial; recruitment; PATIENT RECRUITMENT; MEDICAL INFORMATICS; SYSTEMS; ROUTINE; IMPACT; REPRESENTATION; QUALITY; CARE;
D O I
10.1055/s-0040-1721010
中图分类号
R-058 [];
学科分类号
摘要
Background Even though clinical trials are indispensable for medical research, they are frequently impaired by delayed or incomplete patient recruitment, resulting in cost overruns or aborted studies. Study protocols based on real-world data with precisely expressed eligibility criteria and realistic cohort estimations are crucial for successful study execution. The increasing availability of routine clinical data in electronic health records (EHRs) provides the opportunity to also support patient recruitment during the prescreening phase. While solutions for electronic recruitment support have been published, to our knowledge, no method for the prioritization of eligibility criteria in this context has been explored. Methods In the context of the Electronic Health Records for Clinical Research (EHR4CR) project, we examined the eligibility criteria of the KATHERINE trial. Criteria were extracted from the study protocol, deduplicated, and decomposed. A paper chart review and data warehouse query were executed to retrieve clinical data for the resulting set of simplified criteria separately from both sources. Criteria were scored according to disease specificity, data availability, and discriminatory power based on their content and the clinical dataset. Results The study protocol contained 35 eligibility criteria, which after simplification yielded 70 atomic criteria. For a cohort of 106 patients with breast cancer and neoadjuvant treatment, 47.9% of data elements were captured through paper chart review, with the data warehouse query yielding 26.9% of data elements. Score application resulted in a prioritized subset of 17 criteria, which yielded a sensitivity of 1.00 and specificity 0.57 on EHR data (paper charts, 1.00 and 0.80) compared with actual recruitment in the trial. Conclusion It is possible to prioritize clinical trial eligibility criteria based on real-world data to optimize prescreening of patients on a selected subset of relevant and available criteria and reduce implementation efforts for recruitment support. The performance could be further improved by increasing EHR data coverage.
引用
收藏
页码:17 / 26
页数:10
相关论文
共 50 条
  • [41] Impact of renal function eligibility criteria in clinical trials and real-world survival outcomes among patients with metastatic renal cell carcinoma.
    Miron, Benjamin
    Wang, Xiaoliang
    Hasler, Jill S.
    Royce, Trevor Joseph
    Geynisman, Daniel M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 407 - 407
  • [42] Novel statistical approaches and applications in leveraging real-world data in regulatory clinical studies
    Li, Heng
    Chen, Wei-Chen
    Lu, Nelson
    Wang, Chenguang
    Tiwari, Ram
    Xu, Yunling
    Yue, Lilly Q.
    HEALTH SERVICES AND OUTCOMES RESEARCH METHODOLOGY, 2020, 20 (04) : 237 - 246
  • [43] Novel statistical approaches and applications in leveraging real-world data in regulatory clinical studies
    Heng Li
    Wei-Chen Chen
    Nelson Lu
    Chenguang Wang
    Ram Tiwari
    Yunling Xu
    Lilly Q. Yue
    Health Services and Outcomes Research Methodology, 2020, 20 : 237 - 246
  • [44] Real-World Outcomes of Medicare Fee-for-Service Beneficiaries Meeting the Eligibility Criteria for the DREAMM-7 and DREAMM-8 Clinical Trials
    McNamara, Simon
    Boytsov, Natalie
    Wang, Peter Feng
    Hanna, Maya
    Franco, Anjali
    Lewing, Benjamin
    Kelly, Barth
    Tkacz, Joseph
    BLOOD, 2023, 142
  • [45] Eyes that Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proportion of the Real-World Patient Population and Reasons for Exclusion
    Kim, Jae Hui
    Kim, Jong Woo
    Kim, Chul Gu
    JOURNAL OF OPHTHALMOLOGY, 2021, 2021
  • [46] Using a Federated Network of Real-World Data to Optimize Clinical Trials Operations
    Topaloglu, Umit
    Palchuk, Matvey B.
    JCO CLINICAL CANCER INFORMATICS, 2018, 2 : 1 - 10
  • [47] The changing landscape of cancer cell therapies: clinical trials and real-world data
    Saez-Ibanez, Ana Rosa
    Upadhaya, Samik
    Partridge, Tanya
    Winkelman, Daniel
    Correa, Diego
    Campbell, Jay
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (10) : 736 - 737
  • [48] The evolving role of data & safety monitoring boards for real-world clinical trials
    Bunning, Bryan J.
    Hedlin, Haley
    Chen, Jonathan H.
    Ciolino, Jody D.
    Ferstad, Johannes Opsahl
    Fox, Emily
    Garcia, Ariadna
    Go, Alan
    Johari, Ramesh
    Lee, Justin
    Maahs, David M.
    Mahaffey, Kenneth W.
    Opsahl-Ong, Krista
    Perez, Marco
    Rochford, Kaylin
    Scheinker, David
    Spratt, Heidi
    Turakhia, Mintu P.
    Desai, Manisha
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 7 (01)
  • [49] The era of alternative designs to connect randomized clinical trials and real-world data
    Jeroen W. G. Derksen
    Anne M. May
    Miriam Koopman
    Nature Reviews Clinical Oncology, 2019, 16 : 589 - 589
  • [50] Mimicking Clinical Trials Using Real-World Data: A Novel Method and Applications
    Wang, Wei-Jhih
    Bansal, Aasthaa
    Bennette, Caroline Savage
    Basu, Anirban
    MEDICAL DECISION MAKING, 2023, 43 (03) : 275 - 287